Kennedy Capital Management, Inc. Global Blood Therapeutics, Inc. Transaction History

Kennedy Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $505,827 - $856,749	-13,435 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $444,450 - $627,503	-8,424 Reduced 38.54%	13,435 $741,000
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $7,455 - $12,518	153 Added 0.7%	21,859 $1.38 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $122,781 - $256,629	2,943 Added 15.69%	21,706 $1.11 Million
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $32,035 - $57,383	-701 Reduced 3.6%	18,763 $1.49 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $57,231 - $73,082	-1,262 Reduced 6.09%	19,464 $944,000
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $1.09 Million - $1.31 Million	20,726 New	20,726 $1.09 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.